Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
EyePoint, Inc. - Common Stock
(NQ:
EYPT
)
13.05
+0.46 (+3.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 25, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about EyePoint, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Earnings Scheduled For March 5, 2025
↗
March 05, 2025
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
February 18, 2025
Via
Benzinga
Analyst Ratings For EyePoint Pharmaceuticals
↗
October 25, 2024
Via
Benzinga
EyePoint Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
↗
August 13, 2024
Via
Benzinga
These stocks are moving in today's pre-market session
↗
February 05, 2025
Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
February 05, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 28, 2024
Via
Benzinga
EyePoint's Investigational Drug Shows Early And Sustained Improvement Than Regeneron's Eylea For Diabetes-Associated Vision Loss
↗
October 28, 2024
EyePoint Pharmaceuticals' shares rise as interim Phase 2 VERONA trial data shows Duravyu improves visual acuity and anatomy in diabetic macular edema patients.
Via
Benzinga
Deep Dive Into EyePoint Pharmaceuticals Stock: Analyst Perspectives (4 Ratings)
↗
May 07, 2024
Via
Benzinga
Critical Insights From EyePoint Pharmaceuticals Analyst Ratings: What You Need To Know
↗
March 08, 2024
Via
Benzinga
A Preview Of EyePoint Pharmaceuticals's Earnings
↗
March 06, 2024
Via
Benzinga
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
↗
October 28, 2024
Via
Benzinga
NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday
↗
October 14, 2024
Via
Benzinga
Topics
Government
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
July 12, 2024
Via
Benzinga
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
↗
July 12, 2024
Via
Benzinga
Crocs To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
↗
May 13, 2024
Via
Benzinga
EYPT Stock Earnings: EyePoint Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
↗
May 08, 2024
EYPT stock results show that EyePoint Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
May 08, 2024
Via
Benzinga
Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge
↗
May 06, 2024
Via
Benzinga
Topics
Stocks
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
↗
May 06, 2024
Via
Benzinga
Crude Oil Gains 1%; TreeHouse Foods Shares Fall After Q1 Results
↗
May 06, 2024
Via
Benzinga
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
↗
May 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 06, 2024
Via
Benzinga
Nasdaq Jumps 100 Points; Tyson Foods Sales Miss Views
↗
May 06, 2024
Via
Benzinga
Topics
Earnings
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
↗
May 06, 2024
EyePoint Pharmaceuticals reveals Phase 2 PAVIA trial results for Duravyu in non-proliferative diabetic retinopathy. Positive data showcases Duravyu's efficacy and safety profile.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
May 06, 2024
Via
Benzinga
Over $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
↗
April 23, 2024
Via
Benzinga
EYPT Stock Earnings: EyePoint Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023
↗
March 07, 2024
EYPT stock results show that EyePoint Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
↗
March 04, 2024
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.
Via
Benzinga
Topics
Stocks
Earnings Scheduled For March 7, 2024
↗
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
